利妥昔单抗治疗抗黑色素瘤分化相关蛋白5型皮肌炎合并间质性肺病
Rituximab in Antimelanoma Differentiation-Associated Protein-5 Dermatomyositis with Interstitial Lung Disease.
作者信息
Scirocco Chiara, Gubbiotti Andreina, Sebastiani Alfredo, Sebastiani Gian Domenico
机构信息
UOC di Reumatologia, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy.
UOC di Patologia Clinica, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy.
出版信息
Case Rep Rheumatol. 2020 May 30;2020:8145790. doi: 10.1155/2020/8145790. eCollection 2020.
Abstract
In this paper, we report a challenging case of a middle-age woman who developed antimelanoma differentiation-associated protein-5 dermatomyositis (anti-MDA5 DM) with interstitial lung disease (ILD) and was successfully treated with rituximab (RTX), after failure of a first-line therapy.
摘要
在本文中，我们报告了一例具有挑战性的病例，一名中年女性患抗黑色素瘤分化相关蛋白5皮肌炎（抗MDA5 DM）合并间质性肺疾病（ILD），在一线治疗失败后，使用利妥昔单抗（RTX）成功治愈。
Zotero 插件